Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Carcinoma, Islet Cell
>>
Tyrosine Kinase Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
everolimus
/ Generic mfg.
vatalanib
(PTK787) / Novartis, Bayer
cixutumumab
(IMC A12) / Eli Lilly
gefitinib
/ Generic mfg.
motesanib
(AMG 706) / Takeda
sorafenib
/ Generic mfg.